Your browser doesn't support javascript.
loading
The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens.
Sakae, D Y; Marti, F; Lecca, S; Vorspan, F; Martín-García, E; Morel, L J; Henrion, A; Gutiérrez-Cuesta, J; Besnard, A; Heck, N; Herzog, E; Bolte, S; Prado, V F; Prado, M A M; Bellivier, F; Eap, C B; Crettol, S; Vanhoutte, P; Caboche, J; Gratton, A; Moquin, L; Giros, B; Maldonado, R; Daumas, S; Mameli, M; Jamain, S; El Mestikawy, S.
Afiliação
  • Sakae DY; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Institut de Biologie Paris Seine (IBPS), UM119 Neuroscience Paris Seine, Paris, France.
  • Marti F; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1130, Neuroscience Paris Seine, Paris, France.
  • Lecca S; Centre National de la Recherche Scientifique (CNRS) UMR 8246, Neuroscience Paris Seine, Paris, France.
  • Vorspan F; Department of Psychiatry, Douglas Hospital Research Center, McGill University, Verdun, QC, Canada.
  • Martín-García E; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Institut de Biologie Paris Seine (IBPS), UM119 Neuroscience Paris Seine, Paris, France.
  • Morel LJ; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1130, Neuroscience Paris Seine, Paris, France.
  • Henrion A; Centre National de la Recherche Scientifique (CNRS) UMR 8246, Neuroscience Paris Seine, Paris, France.
  • Gutiérrez-Cuesta J; Department of Psychiatry, Douglas Hospital Research Center, McGill University, Verdun, QC, Canada.
  • Besnard A; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Institut de Biologie Paris Seine (IBPS), UM119 Neuroscience Paris Seine, Paris, France.
  • Heck N; Institut du Fer à Moulin, Paris, France.
  • Herzog E; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 839, Paris, France.
  • Bolte S; Fondation FondaMental, Créteil, France.
  • Prado VF; Institut National de la Santé et de la Recherche Médicale (INSERM), U705, Centre National de la Recherche Scientifique (CNRS) UMR 8206, Université Paris Descartes, Université Denis Diderot, PRES Sorbonne Paris Cité, Paris, France.
  • Prado MA; Assistance Publique-Hôpitaux de Paris, GH Saint Louis-Lariboisière-F Widal, Service de Psychiatrie, Paris, France.
  • Bellivier F; Institut National de la Santé et de la Recherche Médicale (INSERM U955), Psychiatrie Translationnelle, Créteil, France.
  • Eap CB; Departament de Ciencies Experimentals i de la Salut, Universitat Pompeu Fabra, PRBB, Barcelona, Spain.
  • Crettol S; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Institut de Biologie Paris Seine (IBPS), UM119 Neuroscience Paris Seine, Paris, France.
  • Vanhoutte P; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1130, Neuroscience Paris Seine, Paris, France.
  • Caboche J; Centre National de la Recherche Scientifique (CNRS) UMR 8246, Neuroscience Paris Seine, Paris, France.
  • Gratton A; Department of Psychiatry, Douglas Hospital Research Center, McGill University, Verdun, QC, Canada.
  • Moquin L; Fondation FondaMental, Créteil, France.
  • Giros B; Institut National de la Santé et de la Recherche Médicale (INSERM U955), Psychiatrie Translationnelle, Créteil, France.
  • Maldonado R; Université Paris Est, Faculté de Médecine, Créteil, France.
  • Daumas S; Assistance Publique-Hôpitaux de Paris, Hôpital H. Mondor-A Chenevier, Pôle de Psychiatrie, Créteil, France.
  • Mameli M; Departament de Ciencies Experimentals i de la Salut, Universitat Pompeu Fabra, PRBB, Barcelona, Spain.
  • Jamain S; Sorbonne Universités, Université Pierre et Marie Curie (UPMC) Paris 06, Institut de Biologie Paris Seine (IBPS), UM119 Neuroscience Paris Seine, Paris, France.
  • El Mestikawy S; Institut National de la Santé et de la Recherche Médicale (INSERM), UMR-S 1130, Neuroscience Paris Seine, Paris, France.
Mol Psychiatry ; 20(11): 1448-59, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26239290
ABSTRACT
Tonically active cholinergic interneurons (TANs) from the nucleus accumbens (NAc) are centrally involved in reward behavior. TANs express a vesicular glutamate transporter referred to as VGLUT3 and thus use both acetylcholine and glutamate as neurotransmitters. The respective roles of each transmitter in the regulation of reward and addiction are still unknown. In this study, we showed that disruption of the gene that encodes VGLUT3 (Slc17a8) markedly increased cocaine self-administration in mice. Concomitantly, the amount of dopamine (DA) release was strongly augmented in the NAc of VGLUT3(-/-) mice because of a lack of signaling by metabotropic glutamate receptors. Furthermore, dendritic spines and glutamatergic synaptic transmission on medium spiny neurons were increased in the NAc of VGLUT3(-/-) mice. Increased DA and glutamate signaling in the NAc are hallmarks of addiction. Our study shows that TANs use glutamate to reduce DA release and decrease reinforcing properties of cocaine in mice. Interestingly, we also observed an increased frequency of rare variations in SLC17A8 in a cohort of severe drug abusers compared with controls. Our findings identify VGLUT3 as an unexpected regulator of drug abuse.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Dopamina / Ácido Glutâmico / Transtornos Relacionados ao Uso de Cocaína / Predisposição Genética para Doença / Proteínas Vesiculares de Transporte de Glutamato / Núcleo Accumbens Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Dopamina / Ácido Glutâmico / Transtornos Relacionados ao Uso de Cocaína / Predisposição Genética para Doença / Proteínas Vesiculares de Transporte de Glutamato / Núcleo Accumbens Idioma: En Ano de publicação: 2015 Tipo de documento: Article